stockrowJazz Pharmaceuticals PLC
JAZZ Healthcare Biotechnology
Jazz Pharmaceuticals PLC’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 4.88% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −280.5%
- Free cash flow
- −60.4%
- Total debt
- +3.88%
Quarter to September 2026, against a year earlier
Follow JAZZ
Alert me
Jazz Pharmaceuticals PLC (JAZZ) Revenue growth
Jazz Pharmaceuticals PLC's revenue growth over the twelve months to 30 September 2026 was 13.5%, up 8.6 percentage points from fiscal 2025 (4.88%). Over the past ten years it has ranged from 4.78% (fiscal 2023) to 30.9% (fiscal 2021); the current reading is higher than 18% of that period. That is above the Biotechnology industry median of 6.26% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 4.88% | (1.24) |
| FY2024 | 6.12% | 1.34 |
| FY2023 | 4.78% | (13.48) |
| FY2022 | 18.3% | (12.65) |
| FY2021 | 30.9% | 21.57 |
| FY2020 | 9.34% | (4.98) |
| FY2019 | 14.3% | (2.50) |
| FY2018 | 16.8% | 8.03 |
| FY2017 | 8.79% | (3.53) |
| FY2016 | 12.3% | (0.63) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 10.4% | (5.17) |
| Jun 2026 | 15.6% | (3.51) |
| Mar 2026 | 19.1% | 8.97 |
| Dec 2025 | 10.1% | 3.35 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BBIO BridgeBio Pharma, Inc. compare | 167.3% |
| KYMR Kymera Therapeutics, Inc. compare | 134.8% |
| ASND Ascendis Pharma A/S compare | 126.0% |
| HALO Halozyme Therapeutics, Inc. compare | 45.0% |
| BMRN BioMarin Pharmaceutical Inc. compare | 18.1% |
| JAZZ Jazz Pharmaceuticals PLC | 13.5% |
| EXEL Exelixis, Inc. compare | 9.12% |
| TECH Bio-Techne Corp compare | −0.38% |
| SMMT Summit Therapeutics PLC compare | −61.0% |
| Biotechnology industry median | 6.26% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on JAZZ
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement